肝硬化门静脉高压性出血的防治:从外科到内科  

Prevention and Management of Portal Hypertensive Hemorrhage in Cirrhosis:From Surgical to Medical Therapy

作　　者：胡平方[1] 谢渭芬[1] 

机构地区：[1]第二军医大学附属长征医院消化内科,200003

出　　处：《胃肠病学》2014年第2期65-69,共5页Chinese Journal of Gastroenterology

摘　　要：门静脉高压性出血是肝硬化最常见的并发症,其防治手段主要包括外科手术、药物、内镜、介入治疗等。二十世纪八十年代以前,门静脉高压性出血的防治以外科手术为主。近二三十年来,随着药物、内镜、介入等治疗手段的发展,外科分流术和断流术的应用逐渐减少,门静脉高压性出血的防治已由外科治疗为主逐渐进入内科治疗为主的时代。Portal hypertensive hemorrhage is the most severe complication of liver cirrhosis.The prevention and management of portal hypertensive hemorrhage include shunt or devascularization surgery,drugs treatment,endoscopic therapy and interventional therapy.Shunt and devascularization surgery had played major role in the management of portal hypertensive hemorrhage before 1980s.During the past twenty to thirty years,considerable progresses have been made in the aspects of drug treatment,endoscopic and interventional therapy for portal hypertensive hemorrhage.Consequently,the application of surgical shunt and devascularization is reduced gradually.The prevention and management of portal hypertensive hemorrhage have shifted then from surgical to medical therapy.

关 键 词：高血压 门静脉 非选择性Β受体阻滞剂 内镜下静脉曲张硬化剂治疗 内镜下静脉曲张套扎术 门体分流术 经颈静脉肝内 治疗 

分 类 号：R575.2[医药卫生—消化系统]